Cognitive Behavioral Treatment of Pediatric Trichotillomania - Full Text View

Sponsored by:	National Institute of Mental Health (NIMH)
Information provided by:	National Institute of Mental Health (NIMH)
ClinicalTrials.gov Identifier:	NCT00043563

Purpose

This study will compare the effectiveness of cognitive-behavior therapy (CBT) to a minimal attention control (AC) condition for treatment of pediatric trichotillomania (TTM).

Condition	Intervention	Phase
Trichotillomania	Behavioral: Cognitive-Behavior Therapy	Phase I

Study Type:	Interventional
Study Design:	Treatment, Randomized, Open Label, Placebo Control, Single Group Assignment, Efficacy Study
Official Title:	Cognitive Behavioral Treatment of Pediatric Trichotillomania

Further study details as provided by National Institute of Mental Health (NIMH):

Estimated Enrollment:	24
Study Start Date:	January 2001
Estimated Study Completion Date:	December 2003

Detailed Description:

TTM is a persistent impulse control disorder in which the individual acts on urges to pull out his or her own hair. Onset typically occurs by adolescence, and TTM is often associated with significant functional impairment and distress. CBT is a type of psychotherapy designed to change problematic behaviors and thinking. It includes self-monitoring of hair-pulling urges and homework assignments to practice the use of cognitive and behavioral strategies.

Participants are assigned randomly to receive either CBT or AC for 8 weeks. Participants assigned to CBT receive weekly 1-hour sessions of CBT for 8 weeks; participants assigned to AC receive 6 telephone contacts and 2 in-person sessions for 8 weeks. After 8 weeks, CBT participants who respond to treatment enter Phase II, which lasts an additional 8 weeks and includes 4 in-person maintenance sessions. AC participants who are still symptomatic after 8 weeks are offered CBT.

Eligibility

Ages Eligible for Study:	8 Years to 17 Years
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:

Primary diagnosis of Trichotillomania
Minimum symptom duration of 6 months
Presence of a stable parent or guardian

Exclusion Criteria:

Other primary psychiatric diagnosis
Bipolar illness, pervasive developmental disorder, thought disorder, current major depression, ADD/ADHD
Concurrent psychotherapy
Currently receiving psychotropic medications

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00043563

Locations

United States, Pennsylvania
Center for the Treatment and Study of Anxiety
Philadelphia, Pennsylvania, United States, 19104

Sponsors and Collaborators

National Institute of Mental Health (NIMH)

More Information

No publications provided

Study ID Numbers:	R21 MH61457, DSIR CT-S
Study First Received:	August 9, 2002
Last Updated:	November 17, 2005
ClinicalTrials.gov Identifier:	NCT00043563 History of Changes
Health Authority:	United States: Federal Government

Keywords provided by National Institute of Mental Health (NIMH):

Cognitive-behavior Therapy
Minimal Attention Control

Study placed in the following topic categories:

Impulse Control Disorders
Mental Disorders
Trichotillomania

Additional relevant MeSH terms:

Impulse Control Disorders
Mental Disorders
Trichotillomania

ClinicalTrials.gov processed this record on September 10, 2009